Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25297
Title: Eph receptors in the immune-suppressive tumor microenvironment.
Austin Authors: Janes, Peter W ;Vail, Mary E;Ernst, Matthias ;Scott, Andrew M 
Affiliation: Olivia Newton-John Cancer Research Institute
La Trobe University School of Cancer Medicine
Issue Date: 15-Feb-2021
Date: 2020-11-11
Publication information: Cancer Research 2021; 81(4): 801-805
Abstract: The tumor microenvironment (TME) promotes tumor development via complex intercellular signaling, aiding tumor growth and suppressing immunity. Eph receptors and their ephrin ligands control cell interactions during normal development, and re-emerge in tumors and the TME, where they are implicated in invasion, metastasis and angiogenesis. Recent studies also indicate roles for Eph receptors in suppressing immune responses, by controlling tumor interactions with innate and adaptive immune cells within the TME. Accordingly, inhibiting these functions can promote immune response and efficacy of immune-checkpoint inhibition. This research highlights Eph receptors as potential targets to enhance efficacy of immune-based therapies in cancer patients.
URI: https://ahro.austin.org.au/austinjspui/handle/1/25297
DOI: 10.1158/0008-5472.CAN-20-3047
Journal: Cancer Research
PubMed URL: 33177063
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

38
checked on Apr 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.